Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

A.J.M. van den Eertwegh, J.P. Versluis, H.P. van den Berg, S.J.A.M. Santegoets, R.J.A. van Moorselaar, T.M. van der Sluis, H.E. Gall, T.C. Harding, K. Jooss, I. Lowy, H.M. Pinedo, R.J. Scheper, A.G.M. Stam, B.M.E. von Blomberg, T.D. de Gruijl, K. Hege, N. Sacks, W.R. Gerritsen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)509-517
JournalLancet Oncology
Volume13
Issue number5
DOIs
Publication statusPublished - 2012

Cite this

@article{dba36e3cca5c42bfafc0ffcfc005dbc6,
title = "Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial",
author = "{van den Eertwegh}, A.J.M. and J.P. Versluis and {van den Berg}, H.P. and S.J.A.M. Santegoets and {van Moorselaar}, R.J.A. and {van der Sluis}, T.M. and H.E. Gall and T.C. Harding and K. Jooss and I. Lowy and H.M. Pinedo and R.J. Scheper and A.G.M. Stam and {von Blomberg}, B.M.E. and {de Gruijl}, T.D. and K. Hege and N. Sacks and W.R. Gerritsen",
year = "2012",
doi = "10.1016/S1470-2045(12)70007-4",
language = "English",
volume = "13",
pages = "509--517",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "5",

}

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. / van den Eertwegh, A.J.M.; Versluis, J.P.; van den Berg, H.P.; Santegoets, S.J.A.M.; van Moorselaar, R.J.A.; van der Sluis, T.M.; Gall, H.E.; Harding, T.C.; Jooss, K.; Lowy, I.; Pinedo, H.M.; Scheper, R.J.; Stam, A.G.M.; von Blomberg, B.M.E.; de Gruijl, T.D.; Hege, K.; Sacks, N.; Gerritsen, W.R.

In: Lancet Oncology, Vol. 13, No. 5, 2012, p. 509-517.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

AU - van den Eertwegh, A.J.M.

AU - Versluis, J.P.

AU - van den Berg, H.P.

AU - Santegoets, S.J.A.M.

AU - van Moorselaar, R.J.A.

AU - van der Sluis, T.M.

AU - Gall, H.E.

AU - Harding, T.C.

AU - Jooss, K.

AU - Lowy, I.

AU - Pinedo, H.M.

AU - Scheper, R.J.

AU - Stam, A.G.M.

AU - von Blomberg, B.M.E.

AU - de Gruijl, T.D.

AU - Hege, K.

AU - Sacks, N.

AU - Gerritsen, W.R.

PY - 2012

Y1 - 2012

U2 - 10.1016/S1470-2045(12)70007-4

DO - 10.1016/S1470-2045(12)70007-4

M3 - Article

VL - 13

SP - 509

EP - 517

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 5

ER -